I’m certainly no expert in this ASX release of information rules etc., but haven’t we already discussed all this at length about release of information? What the rules of disclosure to the ASX are?
The quarterly did include the information relating to the raising of funds and the issuance of another 300+ million shares for that purpose to sophs/instos. However, there was nothing released about what if anything was located. Why would there be?
This is my understanding of all this - If RDN was to release information now in this quarterly that was not released already, there would be serious questions asked of them as to why that same information was not released to the market earlier in a separate announcement. Especially given it would be price sensitive. You cannot hold back from releasing important information to the market, but then suddenly some weeks later, report it in the quarterly. That’s a huge please explain there.
No, Dusko has said that the results of the assays will be released when they receive them and he was expecting late November. That might happen earlier, who knows. I am expecting a separate announcement when these results are received. He already said he expects a flow of announcements over months. This is ongoing peeps and we will know when we need to know. There is no secrets or conspiracy here.
Yep, it sucks, we are waiting and trying to digest what is happening out there. I am sure Dusko is not deliberately trying to sabotage our mental health. Please everybody use common sense and reason it out for yourself before thinking the worst.
GLTAH.
- Forums
- ASX - By Stock
- RDN
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
RDN
raiden resources limited
Add to My Watchlist
0.00%
!
0.4¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-21
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.80M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $30.16K | 7.387M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
85 | 49580103 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 17688676 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
79 | 46040603 | 0.004 |
39 | 35008156 | 0.003 |
14 | 26357501 | 0.002 |
8 | 32400001 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 14112777 | 17 |
0.006 | 16249002 | 26 |
0.007 | 18059066 | 30 |
0.008 | 8873282 | 10 |
0.009 | 6900000 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RDN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online